Alafia Ai launches AIVAS: The future of AI in healthcare supercomputing

Alafia Ai Inc. has announced the general availability of AIVAS, an all-in-one high-performance personal supercomputer poised to revolutionise the field of artificial intelligence in healthcare. Designed to accelerate the development and deployment of critical AI software applications, AIVAS significantly enhances bioinformatics and in-silico experiments. By offering unmatched computational power, AIVAS aims to provide bioinformaticians and healthcare professionals with advanced tools for pivotal insights in medical applications, including genetics research and clinical decision support systems.

As the complexity of healthcare applications continues to escalate, the need for robust computational power has become more critical. AIVAS addresses this demand by delivering exceptional compute density and energy efficiency. The supercomputer supports high-throughput sequencing algorithms, computational mass spectrometry, and bioinformatics automation, thereby advancing precision and speed in medical research. Its real-time data visualisation and processing capabilities for computed tomography (CT) and magnetic resonance imaging (MRI) scans represent a significant leap forward in medical imaging, enabling faster and more accurate results in various clinical settings.

Alafia Ai’s AIVAS supercomputer revolutionises healthcare with unmatched AI performance and efficiency, transforming bioinformatics and medical research. Photo courtesy of Business Wire.

AIVAS stands out for its impressive specifications, which include over 1,000 trillion operations per second (TOPS) powered by a cloud-native CPU and four NVIDIA GPUs. This setup offers computing capacity equivalent to two full cloud-native AI servers. The system features 128 CPU cores, 256 Single Instruction Multiple Data (SIMD) advanced vector engines, and 28,416 NVIDIA CUDA GPU cores. With 92 gigabytes of high-bandwidth GPU unified memory and 2,048 gigabytes of unified system memory, AIVAS ensures high precision and rapid processing of large datasets. Despite its power, the supercomputer operates with remarkable energy efficiency, consuming only 700 watts.

The extensive software support available with AIVAS includes access to over 1,000 validated and verified packages, ranging from genomic alignment to sequence mapping. Regular updates ensure stability and compliance with the highest standards of privacy and security. Researchers and clinicians benefit from full control over data, algorithms, and applications, enhancing the reliability and protection of their work.

AIVAS has already garnered enthusiasm from early adopters in the bioinformatics community, including researchers from Stanford Medical School’s Department of Neurology and Acacia Clinics. Dr. Danielle D. DeSouza, Vice-President of Research at Acacia Clinics and a researcher at Stanford University, praised AIVAS for its efficiency, noting that it significantly reduced the time required for cortical reconstructions and clinical trial pre-processing. This capability demonstrates AIVAS’s potential to transform healthcare by facilitating real-time reconstructions and improving performance in medical imaging and bioinformatics.

As healthcare technology evolves, AIVAS stands at the forefront of this transformation, offering tools that will drive new insights and enhance patient care. With its advanced capabilities, AIVAS is set to become an essential asset in the quest for more accurate and efficient medical research and treatment solutions.